Sickle Cell Disease Research Paper

1327 Words3 Pages

Sickle cell disease (SCD) is one of the most common human genetic disorders. SCD is a pleiotropic genetic disorder, meaning that one mutation affects a wide variety of physical characteristics (15). currently affects 90,000 Americans and over 275,000 newborn infants annually worldwide (8). The average life expectancy has been calculated to be about 53 and 58 years for men and women respectively (10). The term Sickle cell disease actually refers to all of the various mutagenic genotypes that cause the various clinical manifestations otherwise known as a syndrome (1). In this condition, hemoglobin proteins of erythrocytic blood cells are misshapen, so the oxygen carrying capability is affected (2). SCD was first described by the physician James …show more content…

Normal erythrocytes are very elastic and spherical in shape, which aids them in traveling through narrow blood vessels, such as capillaries. The structure of hemoglobin also aids in the ability to effectively carry four molecules of oxygen. However, the sickling of HbS hemoglobin causes the cells to stiffen and become sticky (14). The change in shape causes issues with the ability to carry oxygen in hemoglobin and it also causes erythrocytes to clog capillaries at times (14). Due to the shape of the erythrocytes, they also are destroyed quicker than normal red blood cells (14). Normal erythrocytes are able to operate within the body for 90 to 120 days, but sickled red bloods cells only last 10 to 20 days (14). This issue is what causes sickle cell …show more content…

A barrage of testing is then needed, including: CBC, MCV, and reticulocyte count (5). Further genetic testing can reveal the exact genotype, such as hemoglobin electrophoresis and high performance liquid chromatography (5). Following precautions should be taken in newly diagnosed SCD patients, usually newborns; including: regular immunizations, antibiotic prophylaxis (protection prior to infection onset), and family education (5). It is recommended that all sicknesses experienced be treated aggressively due to the nature of recurrent infections and comorbidities suffered by these patients (5).
Currently, the best treatment available for sickle cell disease is observation through regular testing and then management of the associated symptoms (1). Hydroxyurea is a medication that helps prevent sickle cell crisis and reduces the number of need blood transfuses is those with HbS mutation (7). This therapy works by interfering with the polymerization process during formation of the defect hemoglobin S protein (7). Supplementation with multi-vitamins and folic acid are also recommended in these patients due to the associated iron deficiencies

More about Sickle Cell Disease Research Paper

Open Document